Skip to main content
. 2024 May 2;16(5):e59533. doi: 10.7759/cureus.59533

Table 4. Vital signs analysis among both groups .

Variables Methocarbamol (no. 55) Nefopam (no. 55) P-value
Systolic blood pressure At administration (Mean ± SD) 137.17±9.06 135.19±7.94 0.08
After 1 hour (Mean ± SD) 135.24±7.96 133.56±7.31 0.06
After 6 hours (Mean ± SD) 138.29±5.46 137.64±6.21 0.064
After 12 hours (Mean ± SD) 129.0±6.82 127.41±5.22 0.057
Diastolic blood pressure At administration (Mean ± SD) 83.96±6.40 85.56±8.22 0.421
After 1 hour (Mean ± SD) 82.83±7.50 84.70±8.81 0.058
After 6 hours (Mean ± SD) 79.45±4.67 80.66±6.14 0.069
After 12 hours (Mean ± SD) 81.94±5.99 77.92±6.44 0.052
Pulse rate At administration (Mean ± SD) 98.06±10.3 96.04±4.86 0.053
After 1 hour (Mean ± SD) 105.74±6.58 110.22±6.30 0.058
After 6 hours (Mean ± SD) 99.32±7.05 108.81±9.97 0.031
After 12 hours (Mean ± SD) 97.82±7.81 97.08±8.17 0.485